No More Guessing On Device Scrutiny: EU Regulatory Texts now Out
This article was originally published in SRA
The consolidated texts of the EU's medical device regulation and IVD regulation are now publicly available on the website of the European Parliament, two weeks earlier than expected1. And the publication of the documents mean companies can know with certainty how they might be impacted by the new rules, particularly concerning thorny issues such as the scrutiny of high-risk devices.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies